You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 5,951,974


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,951,974
Title: Interferon polymer conjugates
Abstract:Compositions containing alpha interferon conjugated to a substantially non-antigenic polymer are disclosed in which at least about 30% of the conjugates include covalent attachment of the alpha interferon to the substantially non-antigenic polymer at a histidine. Also disclosed is a process for preparing the conjugates. The process includes contacting an alpha interferon with a succinimidyl carbonate-activated substantially non-antigenic polymer at a pH which is sufficient to facilitate covalent attachment of the polymer on a histidine of the alpha interferon.
Inventor(s): Gilbert; Carl W. (Powder Springs, GA), Park-Cho; Myung-ok (Seoul, KR)
Assignee: Enzon, Inc. (Piscataway, NJ)
Application Number:08/994,622
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Scope and Claims of United States Patent 5,951,974

Introduction

When evaluating a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the details of United States Patent 5,951,974, exploring its claims, scope, and the broader patent landscape.

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of protection granted to the inventor. They must be clear, concise, and supported by the patent's description and drawings[3].

Independent and Dependent Claims

Patent claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. The number and length of these claims can indicate the breadth and complexity of the patent[3].

Patent Scope

The scope of a patent is a critical aspect that determines what is protected and what is not. It is often measured using metrics such as independent claim length and independent claim count. Narrower claims are generally associated with a higher probability of grant and a shorter examination process, while broader claims may face more scrutiny and potential litigation[3].

United States Patent 5,951,974: An Overview

To analyze the scope and claims of United States Patent 5,951,974, we need to examine the patent document itself.

Title and Abstract

The title and abstract provide a preliminary understanding of the invention. Although the specific details of this patent are not provided in the sources, typically, the title would indicate the main subject matter, and the abstract would give a brief summary of the invention.

Claims

The claims section is where the legal boundaries of the invention are defined. Here, you would find both independent and dependent claims that outline what the inventor considers to be their unique contribution.

Description and Drawings

The description and drawings support the claims by providing detailed explanations and visual representations of the invention. This section ensures that the claims are enabled and supported, which is a requirement for patentability.

Analyzing the Claims of Patent 5,951,974

Claim Structure

  • Independent Claims: These claims define the invention in its broadest terms. They are self-contained and do not refer to any other claims.
  • Dependent Claims: These claims build upon the independent claims, adding additional limitations to narrow the scope.

Claim Length and Count

Research suggests that the length and count of independent claims can be indicative of the patent's scope. Shorter, more focused claims are often preferred as they are clearer and less likely to be challenged[3].

Patent Examination Process

The examination process plays a significant role in shaping the final scope of the patent. During this process, the patent office may require the inventor to narrow the claims to ensure they are novel, non-obvious, and enabled.

Office Actions and Responses

Office actions from the patent office can indicate areas where the claims may be too broad or lack clarity. The inventor's responses to these actions can help refine the claims, making them more specific and enforceable.

Broader Patent Landscape

Prior Art and Citations

The Common Citation Document (CCD) and other tools like the Patent Public Search and Global Dossier can help identify prior art and citations related to the patent. This is crucial for understanding how the patent fits into the existing technological landscape[1].

International Patent Offices

For patents with international implications, searching databases from other intellectual property offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) can provide a comprehensive view of the global patent landscape[1].

Legal and Market Implications

Litigation and Licensing

The scope and claims of a patent can significantly impact its legal and market implications. Broader claims may lead to increased litigation costs and licensing complexities, while narrower claims may offer clearer boundaries but potentially less market protection[3].

Market Domination

A well-defined patent with clear and enforceable claims can be a powerful tool for market domination. It allows the inventor to protect their innovation and prevent others from making, using, or selling the invention without permission.

Tools for Patent Search and Analysis

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and analyzing patent claims. It provides modern interfaces and enhanced access to prior art, improving the overall patent searching process[1].

Global Dossier

The Global Dossier service allows users to access the file histories of related applications from participating IP offices, providing a comprehensive view of the patent family and related citations[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for detailed analysis of patent claims and scope[1].

Key Takeaways

  • Clear Claims: Clear and concise claims are essential for defining the scope of a patent.
  • Examination Process: The patent examination process can significantly refine the claims, making them more specific and enforceable.
  • Prior Art: Understanding prior art and citations is crucial for determining the novelty and non-obviousness of the invention.
  • International Landscape: Searching international patent databases can provide a comprehensive view of the global patent landscape.
  • Legal and Market Implications: The scope and claims of a patent have significant legal and market implications, affecting litigation, licensing, and market protection.

FAQs

Q: What is the importance of independent claims in a patent? A: Independent claims define the invention in its broadest terms and are self-contained, making them critical for determining the scope of the patent.

Q: How does the patent examination process affect the scope of a patent? A: The examination process can require the inventor to narrow the claims to ensure they are novel, non-obvious, and enabled, thereby refining the scope of the patent.

Q: What tools are available for searching prior art related to a patent? A: Tools such as the Patent Public Search, Global Dossier, and databases from international intellectual property offices are available for searching prior art.

Q: Why is it important to analyze the claims of a patent? A: Analyzing the claims helps in understanding the legal boundaries of the invention, which is crucial for determining its validity, enforceability, and market implications.

Q: How can the scope of a patent impact its market domination? A: A well-defined patent with clear and enforceable claims can protect the inventor's innovation, preventing others from making, using, or selling the invention without permission, thereby aiding in market domination.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USPTO - Untitled: https://www.uspto.gov/sites/default/files/web/offices/pac/dapp/opla/term/certs/5951974.pdf
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. U.S. Department of Commerce - U.S. Patent and Trademark Office: https://www.commerce.gov/bureaus-and-offices/uspto
  5. Justia Law - Farmer Brothers Co. v. Coca-Cola Co.: https://law.justia.com/cases/federal/district-courts/FSupp/384/595/1370805/

More… ↓

⤷  Subscribe

Details for Patent 5,951,974

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Llc PEGINTRON peginterferon alfa-2b Injection 103949 January 19, 2001 5,951,974 2013-11-10
Merck Sharp & Dohme Llc SYLATRON peginterferon alfa-2b For Injection 103949 March 29, 2011 5,951,974 2013-11-10
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 5,951,974

Country Patent Number Estimated Expiration
South Africa 9811590 ⤷  Subscribe
South Africa 969557 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 9932139 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 9718832 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 9513090 ⤷  Subscribe
United States of America 6042822 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.